NEW YORK, April 8, 2026
Avista Healthcare Partners has announced the acquisition of Bentec Medical from Greyrock Capital Group and Hermitage Equity Partners, marking a significant strategic move to strengthen its presence in the medical device manufacturing sector. The transaction highlights continued momentum in healthcare-focused private equity investments, particularly in high-growth, specialized contract manufacturing platforms that support critical medical technologies. Financial terms of the deal were not disclosed.
Strategic Expansion in Silicone-Based Medical Devices
Founded in 1994 and headquartered in Woodland, California, Bentec Medical has built a strong reputation as a leading manufacturer of complex silicone-based medical device components and finished products. The company serves a wide range of original equipment manufacturer (OEM) customers, along with hospitals and surgical centers, delivering solutions across multiple therapeutic areas including ENT, oncology, aesthetics, biliary surgery, and neonatal care.
Bentec’s success is driven by its proprietary silicone processing technologies, deep engineering expertise, and ability to deliver highly customized, mission-critical components. These capabilities have enabled the company to maintain long-standing relationships with blue-chip medtech customers while achieving consistent quality performance and high customer retention rates. The acquisition aligns with Avista’s strategy of investing in platform companies that are deeply embedded within healthcare delivery and manufacturing ecosystems.
Growth Acceleration Through Innovation and Scale
Advertisement
Under Avista’s ownership, Bentec is expected to accelerate its growth trajectory through targeted investments in innovation, production capacity, and geographic expansion. The partnership aims to enhance Bentec’s capabilities in developing next-generation silicone-based medical technologies, while also pursuing strategic acquisitions to broaden its product portfolio and market reach.
Avista brings more than two decades of experience in scaling healthcare businesses, particularly in medical device and contract manufacturing sectors, positioning Bentec to benefit from operational expertise, capital resources, and strategic guidance. The company’s focus will remain on expanding its advanced manufacturing capabilities while maintaining its strong reputation for quality, reliability, and customer-centric service.
Bentec’s leadership emphasized that the collaboration will enable the company to drive innovation and deliver enhanced value to OEM partners and healthcare providers, ensuring continued leadership in complex silicone device development. The combination of Bentec’s technical strengths and Avista’s growth-oriented investment approach is expected to create a robust platform for long-term value creation.
M&A Momentum Reflects Strong MedTech Investment Trends
This acquisition underscores the growing interest among private equity firms in specialized medtech manufacturing companies, which play a critical role in enabling innovation across the healthcare industry. As demand for advanced medical devices continues to rise, manufacturers with niche expertise and scalable operations are becoming increasingly attractive investment targets.
Greyrock Capital Group, which originally invested in Bentec in 2016, highlighted the company’s strong operational performance, high-quality culture, and sustained financial growth during its ownership period. The transition to Avista reflects a natural progression toward scaling the business to the next level, supported by a partner with deep domain expertise in healthcare investments.
The deal also illustrates broader M&A activity within the medical device sector, where consolidation and strategic partnerships are driving innovation, efficiency, and global expansion. For Avista, the acquisition of Bentec represents another step in building a diversified portfolio of high-performing healthcare assets, reinforcing its position as a leading investor in growth-oriented medical technology platforms.
As the healthcare industry continues to evolve, partnerships like this are expected to play a pivotal role in advancing cutting-edge medical technologies, improving patient outcomes, and supporting the next wave of innovation in device manufacturing.
Source: Avista Healthcare Partners press release
